Ameritas Investment Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Ameritas Investment Partners's CDNA Position: Q2 2026 in Review
Ameritas Investment Partners increased its CareDx (CDNA) stake by 2.2% in Q2 2026, buying an estimated $2.2K and bringing the position to 4,655 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1657.
Ameritas Investment Partners first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $359K in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Ameritas Investment Partners held 4,655 shares of CareDx worth $133K as of Q2 2026.
- Ameritas Investment Partners bought 101 CareDx shares in Q2 2026, an estimated $2.2K.
- CareDx made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1657 holding.
- Ameritas Investment Partners first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
- Ameritas Investment Partners's CareDx position peaked at $359K in Q2 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.